Tuesday 27 May 2025 (12:00-13:00 CET)
Advancing innovative cancer therapies depends on robust clinical research. Yet, geographic disparities, clinical barriers, and regulatory challenges limit equal access to this research for European patients. Moreover, as cancer clinical trials are often conducted in a few cities across Europe, with a dedicated infrastructure and under strict protocols, they often fail to represent real-world populations.
So what are the solutions to improve access to trials for innovative cancer therapies? How should regulatory frameworks be adapted? What is the potential for decentralized clinical trials to improve access, diversity and retention in trials? Join us to find out!
Luis Castelo-Branco, Nova Medical School, Portugal (Keynote)
Eva Jolly, Karolinska Comprehensive Cancer Centre, Sweden
Iwona Ługowska, Maria Skłodowska-Curie National Institute of Oncology, Poland
Wolfgang Fecke, Association of European Cancer Leagues
Moderators: Dheepa Rajan & Erica Richardson (European Observatory on Health Systems and Policies)
Observatory Spotlight Series on beating cancer in Europe
The upcoming Observatory Spotlight Series will tackle critical topics when it comes to cancer prevention and care across Europe: accelerating cancer policy implementation, equitable access to innovative therapies, and reducing inequalities in both within and between countries. Save the dates for the first three webinars in the series and register to attend live or receive the recording.
These webinars will be followed by a mini-series on cancer
screening in the autumn. Watch this space and stay subscribed to the
Observatory newsletter to receive the latest announcements as soon as
registrations open in the later part of the year.